As we enter 2025, the confluence of scientific advancement, market opportunity and industry validation suggests women's ...

A former employee of Stanford University was found guilty of accessing a clinical research database for a multisite breast cancer study and altering patient records after her authorization was revoked ...

A jury found Naheed Mangi replaced patient medical data with erroneous information, insults about former boss.

Roche’s U.S. biotech subsidiary Genentech has wiped its website of past diversity reports as the company’s diversity and ...

A former Stanford employee was convicted of altering data used in a breast cancer study after she was fired, according to the United States Department of Justice. Naheed Mangi, 66, ...

The campaign is based on the results of a survey that reveals the experiences of patients and caregivers in their communities ...

Genentech and Novartis have teamed up with Food Allergy Research & Education (FARE) to enhance the safety of children with ...

If this CEO succeeds N-Power could save millions of dollars and lives in the fight against cancer. "The impact for cancer ...

Roche’s subsidiary Genentech has shared positive Phase III data with the US Food and Drug Administration (FDA) as the company targets the billion-dollar lupus market for its CD20-targeting drug Gazyva ...

Genentech had aimed by this year to double Black and Hispanic representation of directors and officers and extended leadership, among a range of commitments listed on reports and a version of its ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Susvimo ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved a New ...